Prime Medicine Inc (NAS:PRME)
$ 3.15 +0.070 (+2.27%) Market Cap: 571.34 Mil Enterprise Value: 627.39 Mil PE Ratio: 0 PB Ratio: 0.28 GF Score: 33/100

Prime Medicine, Inc at Goldman Sachs Healthcare Conference Transcript

Jun 10, 2026 / 02:40 PM GMT
Release Date Price: $2.71 (-5.90%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

PRME.OQ - Prime Medicine, Inc
Prime Medicine, Inc at Goldman Sachs Healthcare Conference
Jun 10, 2026 / 02:40PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning, everyone, and thank you for joining us. And it's my pleasure to introduce Prime here.

And with us, we have Dr. Alan Rein, CEO of the company.

Alan, to start here, can you provide a high-level overview of where the company stands today and what updates we can anticipate as we look to the second-half of this year and beyond?

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Yeah, so where we stand today is if you think about the company was founded five, six years ago.

Really to carry forward this great technology, which is
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot